ENDV (Endonovo Therapeutics) OCF Margin %: 0.00% (As of Jun. 2025)


What is Endonovo Therapeutics OCF Margin %?

Endonovo Therapeutics ENDV OCF Margin % is 0.00% as of Jun. 2025. The stock has 3 warning signs investors should review. Among 960 Biotechnology companies, Endonovo Therapeutics ranks better than 99.58% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Endonovo Therapeutics's Cash Flow from Operations for the three months ended in Jun. 2025 was $-0.03 Mil. Endonovo Therapeutics's Revenue for the three months ended in Jun. 2025 was $0.00 Mil. Therefore, Endonovo Therapeutics's OCF Margin % for the quarter that ended in Jun. 2025 was 0.00%.

As of today, Endonovo Therapeutics's current OCF Yield % is 42.54%.

The historical rank and industry rank for Endonovo Therapeutics's OCF Margin % or its related term are showing as below:

ENDV' s OCF Margin % Range Over the Past 10 Years
Min: -25475   Med: -661.32   Max: 1000
Current: 770

During the past 13 years, the highest OCF Margin % of Endonovo Therapeutics was 1000.00%. The lowest was -25475.00%. And the median was -661.32%.

ENDV's OCF Margin % is ranked better than
99.58% of 960 companies
in the Biotechnology industry
Industry Median: -68.59 vs ENDV: 770.00

Endonovo Therapeutics OCF Margin % Related Terms

Endonovo Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Endonovo Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endonovo Therapeutics OCF Margin % Chart

Endonovo Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -446.99 -1,352.05 -502.96 87.14 1,000.00

Endonovo Therapeutics Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.00 0.00 0.00 0.00 0.00

ENDV vs RGBP, IOBTQ, CNBX: OCF Margin % Comparison

For the Biotechnology subindustry, Endonovo Therapeutics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Endonovo Therapeutics OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Endonovo Therapeutics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Endonovo Therapeutics's OCF Margin % falls into.


Endonovo Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Endonovo Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=0.1/0.01
=1,000.00 %

Endonovo Therapeutics's OCF Margin for the quarter that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=-0.025/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Endonovo Therapeutics (ENDV) has a OCF Margin % of 0.00% as of Jun. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Endonovo Therapeutics and its competitors. According to the industry distribution chart, Endonovo Therapeutics ranks #4 out of 960 companies in the Biotechnology industry, placing it in the top 0.40000000000001%.
Is Endonovo Therapeutics' OCF Margin % too high?
Endonovo Therapeutics' current OCF Margin % is 0.00%. Based on the distribution chart, Endonovo Therapeutics ranks #4 out of 960 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Endonovo Therapeutics' OCF Margin % compare to RGBP and IOBTQ?
According to the Biotechnology industry distribution chart, Endonovo Therapeutics ranks #4 out of 960 companies for OCF Margin %. This places Endonovo Therapeutics in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Endonovo Therapeutics and its competitors. Endonovo Therapeutics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Endonovo Therapeutics stock overvalued right now?
Endonovo Therapeutics (ENDV) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Endonovo Therapeutics (ENDV), the current OCF Margin % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Endonovo Therapeutics Business Description

Address 6320 Canoga Avenue, 15th Floor, Woodland Hills, CA, USA, 91367
Endonovo Therapeutics Inc develops, manufactures and distributes revolutionary medical devices that utilize Pulsed Electro Magnetic Field (PEMF) therapy that are focused on the rapid recovery of wounds and reduction of pain, edema and inflammation on and in the human body.